B. Messahel

发表

Amplification and Overexpression of CACNA1E Correlates with Relapse in Favorable Histology Wilms' Tumors

Kathy Pritchard-Jones, Chris Jones, Boo Messahel, 2006, Clinical Cancer Research.

Treatment and outcome of Wilms' tumour patients: an analysis of all cases registered in the UKW3 trial.

A. Kelsey, K. Pritchard-Jones, B. Messahel, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Outcomes of non-anaplastic stage III and 'inoperable' Wilms tumour treated in the UKW3 trial.

Roger E. Taylor, A. Kelsey, K. Pritchard-Jones, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Tumours of the central nervous system

D. Hargrave, B. Messahel, P. Plowman, 2004 .

Subtype-Specific FBXW7 Mutation and MYCN Copy Number Gain in Wilms' Tumor

M. Gessler, N. Sebire, T. Chagtai, 2010, Clinical Cancer Research.

Olive ingestion causing a false suspicion of relapsed neuroblastoma: A case of “oliveblastoma?”

B. Messahel, N. Flynn, S. Hogg, 2018, Pediatric blood & cancer.

Efficacy and tolerability of high‐dose methotrexate in central nervous system positive or relapsed lymphoproliferative disease following liver transplant in children

C. R. Pinkerton, K. Pritchard-Jones, N. Hadžić, 2007, British journal of haematology.

Single agent efficacy of rituximab in childhood immunosuppression related lymphoproliferative disease: a United Kingdom Children's Cancer Study Group (UKCCSG) retrospective review

N. Hadžić, B. Messahel, I. Hann, 2006, Leukemia & lymphoma.

Relapsed intracranial ependymoma in children in the UK: patterns of relapse, survival and therapeutic outcome.

C. R. Pinkerton, D. Ellison, T. Jaspan, 2009, European journal of cancer.

Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: An approach to identify candidate genes involved in tumor development

G. Schaaf, M. Kool, Mohamed Hamdi, 2009, Genes, chromosomes & cancer.

Multifaceted Dysregulation of the Epidermal Growth Factor Receptor Pathway in Clear Cell Sarcoma of the Kidney

J. Reis-Filho, D. Bax, Chris Jones, 2007, Clinical Cancer Research.

Complex patterns of chromosome 9 alterations including the p16INK4a locus in Wilms tumours

J. Reis-Filho, R. Natrajan, K. Pritchard-Jones, 2007, Journal of Clinical Pathology.

Clinical features of molecular pathology of solid tumours in childhood.

R. Nash, K. Pritchard-Jones, B. Messahel, 2005, The Lancet. Oncology.

G21(P) Investigating vincristine neurotoxicity in paediatric haematology/oncology patients: A role for genotyping

B. Messahel, E. Richards, S. Guram, 2016 .

Allele loss at 16q defines poorer prognosis Wilms tumour irrespective of treatment approach in the UKW1-3 clinical trials: a Children's Cancer and Leukaemia Group (CCLG) Study.

N. Sebire, Chris Jones, R. A’Hern, 2009, European journal of cancer.

Surgical complications after immediate nephrectomy versus preoperative chemotherapy in non-metastatic Wilms' tumour: findings from the 1991-2001 United Kingdom Children's Cancer Study Group UKW3 Trial.

K. Pritchard-Jones, B. Messahel, M. Powis, 2013, Journal of pediatric surgery.

Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group.

D. Machin, A. Kelsey, K. Pritchard-Jones, 2006, European journal of cancer.

Blastemal expression of type I insulin-like growth factor receptor in Wilms' tumors is driven by increased copy number and correlates with relapse.

J. Reis-Filho, Chris Jones, R. Natrajan, 2006, Cancer research.

c-KIT overexpression, without gene amplification and mutation, in paediatric renal tumours

J. Reis-Filho, D. Bax, Chris Jones, 2007, Journal of Clinical Pathology.

Clinical Benefit of Crenolanib, with or without Salvage Chemotherapy, in Multiply Relapsed, FLT3 Mutant AML Patients after Prior Treatment with Gilteritinib

A. Goldberg, M. Geyer, M. Grunwald, 2020 .

Comparative genomic hybridization and BUB1B mutation analyses in childhood cancers associated with mosaic variegated aneuploidy syndrome.

N. Rahman, S. Hanks, J. Shipley, 2006, Cancer letters.

Younger Patients with Newly Diagnosed FLT3-Mutant AML Treated with Crenolanib Plus Chemotherapy Achieve Adequate Free Crenolanib Levels and Durable Remissions

R. Collins, A. Goldberg, R. Stone, 2019, Blood.

Tolerability and Efficacy of Crenolanib and Cytarabine/Anthracycline Chemotherapy in Older Patients (Aged 61 to 75) with Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML)

A. Goldberg, M. Tallman, R. Stone, 2019, Blood.

How to use… lymph node biopsy in paediatrics

S. Behjati, B. Messahel, Sarah J. Farndon, 2017, Archives of Disease in Childhood: Education & Practice Edition.

No correlation between estimated and actual glomerular filtration rates in pediatric oncology patients

B. Messahel, M. Murray, Lena Uzunova, 2015, Pediatric blood & cancer.

Expression of Hepatocyte Growth Factor and Its Receptor Met in Wilms' Tumors and Nephrogenic Rests Reflects Their Roles in Kidney Development

J. Reis-Filho, N. Sebire, Chris Jones, 2009, Clinical Cancer Research.

Crenolanib versus midostaurin combined with induction and consolidation chemotherapy in newly diagnosed FLT3 mutated AML.

A. Goldberg, R. Stone, A. Fathi, 2019, Journal of Clinical Oncology.

Efficacy and tolerability of high‐dose methotrexate in central nervous system positive or relapsed lymphoproliferative disease following liver transplant in children

K. Pritchard-Jones, N. Hadžić, B. Messahel, 2007, British journal of haematology.